INTERVENTION OF AUTOANTIBODY IN THE MEMBRANE PHOSPHOLIPID FLIP-FLOP OF TROPHOBLAST CELLS.

自身抗体对滋养层细胞膜磷脂触发器的干预。

基本信息

项目摘要

Antiphospholipid antibody is an autoantibody associated with antiphospholipid syndrome (APS) representing arterial and venous thrombosis, thrombocytopenia, and recurrent fetal loss. The underlying mechanism of these complications is not fully understood, while they are obviously due to accelerated coagulation. Since a negatively charged phospholipid, phosphatidylserine, which potentially triggers blood coagulation, is exposed to the outer leaflet of plasma membrane during apoptosis and trophoblast differentiation, we focused on the proteins binding to negatively charged phospholipids in order to delineate the pathogenesis of APS. An affinity column, in which cardiolipin or phosphatidylserine was embedded in octyl cellulose was prepared, and the plasma proteins bound to these phospholipids were collected by elution with 2M NaCl. A proteins were separated by iD or 2D electrophoresis, and then identified by peptide mass fingerprinting. The proteins included beta2 glycoprotein I, inter-alpha-trypsin inhibitor family heavy chain-related protein (IHRP), complement factor 4, factor H and factor H-related protein I. The binding of factor H was interesting, since factor H mutations cause hemolytic uremic syndrome with characteristic pathology of renal microvascular thrombosis, which also occurs in APS. Recently, the crucial role of alternative complement pathway activation has been reported. Thus, possible involvement of factor H, a regulatory protein of alternative pathway, would be an attractive speculation to delineate the pathogenesis of APS.
抗磷脂抗体是一种与抗磷脂综合征(APS)相关的自身抗体,表现为动脉和静脉血栓形成、血小板减少和复发性流产。这些并发症的潜在机制尚不完全清楚,但它们显然是由于加速凝血。由于带负电荷的磷脂,磷脂酰丝氨酸,这可能会触发血液凝固,暴露于细胞凋亡和滋养层分化过程中的质膜外叶,我们专注于蛋白结合带负电荷的磷脂,以描绘APS的发病机制。制备了将心磷脂或磷脂酰丝氨酸包埋在辛基纤维素中的亲和柱,并通过用2M NaCl洗脱收集与这些磷脂结合的血浆蛋白。通过iD或2D电泳分离A蛋白,然后通过肽质量指纹图谱鉴定。这些蛋白质包括β 2糖蛋白I、α胰蛋白酶抑制剂家族间重链相关蛋白(IHRP)、补体因子4、H因子和H因子相关蛋白I。H因子的结合很有趣,因为H因子突变会导致溶血性尿毒综合征,伴有肾微血管血栓形成的特征性病理,这也发生在APS中。最近,已报道了补体旁路途径激活的关键作用。因此,作为旁路途径的调节蛋白,H因子可能参与APS的发病机制是一个有吸引力的推测。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
和田芳直, 坂本真由美: "抗リン脂質抗体の新しい分子病態論に向けて"大阪府立母子保健総合医療センター雑誌. 17. 54-61 (2001)
和田义直、坂本真由美:“抗磷脂抗体的新分子发病机制”《大阪府立母子保健医疗中心杂志》17. 54-61(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wada Y.: "Exposure of phosphatidylserin and complements"in Annual Review Immunology 2004 (Eds. Okumura, Hirano, Satou) (Chugaiigakusha, Tokyo.). 277-283
Wada Y.:“磷脂酰丝氨酸和补体的暴露”,2004 年免疫学年度评论(Okumura、Hirano、Satou 编)(Chugaiigakusha,东京)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WADA Yoshinao其他文献

WADA Yoshinao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WADA Yoshinao', 18)}}的其他基金

Glycoproteomic reasearch to reveal the frequency and diversity of the Congenital Disorders of Glycosylation
糖蛋白质组学研究揭示先天性糖基化障碍的频率和多样性
  • 批准号:
    23390081
  • 财政年份:
    2011
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic Research on Congenital Disorders of Glycosylation (CDG)
先天性糖基化障碍(CDG)的基础研究
  • 批准号:
    19390093
  • 财政年份:
    2007
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Antiphospholipid syndrome : Elucidation of molecular mechanism to give insights into new therapeutic approach
抗磷脂综合征:阐明分子机制以深入了解新的治疗方法
  • 批准号:
    16390123
  • 财政年份:
    2004
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
INVOLVEMENT OF ANNEXIN V IN THE ENDOTHELIAL APOPTOSIS INDUCED BY AUTOANTIBODIES.
膜联蛋白 V 参与自身抗体诱导的内皮细胞凋亡。
  • 批准号:
    10670441
  • 财政年份:
    1998
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Revealing the mechanism of phosphatidylserine asymmetry establishment and maintenance in the plasma membrane
揭示质膜中磷脂酰丝氨酸不对称性建立和维持的机制
  • 批准号:
    23K05762
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Phosphatidylserine-blocking nanoparticles as improved anti-thrombotic with reduced bleeding risk
磷脂酰丝氨酸阻断纳米颗粒可改善抗血栓形成并降低出血风险
  • 批准号:
    10598788
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
Regulation of endothelial cell phosphatidylserine in thrombosis
血栓形成中内皮细胞磷脂酰丝氨酸的调节
  • 批准号:
    10541214
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis
强毒立克次体利用巨噬细胞上的 CD300f 磷脂酰丝氨酸结合受体进行宿主定植和发病机制
  • 批准号:
    10526450
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Analysis of the role of phosphatidylserine-binding proteins accumulated in dental plaque and their relevance to the onset of periodontitis
分析牙菌斑中积累的磷脂酰丝氨酸结合蛋白的作用及其与牙周炎发病的相关性
  • 批准号:
    22K09937
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
靶向磷脂酰丝氨酸/TAM 受体/PD-L1 轴作为癌症的脆弱性
  • 批准号:
    10554443
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Regulation of endothelial cell phosphatidylserine in thrombosis
血栓形成中内皮细胞磷脂酰丝氨酸的调节
  • 批准号:
    10348804
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
靶向磷脂酰丝氨酸/TAM 受体/PD-L1 轴作为癌症的脆弱性
  • 批准号:
    10365623
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis
强毒立克次体利用巨噬细胞上的 CD300f 磷脂酰丝氨酸结合受体进行宿主定植和发病机制
  • 批准号:
    10674996
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Mechanisms of natural phosphatidylserine exposure in the nervous system
神经系统中天然磷脂酰丝氨酸暴露的机制
  • 批准号:
    10428834
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了